Abstract
BackgroundThe marketing authorisation for many injectable drugs used in palliative care does not cover the frequently preferred subcutaneous route. Consequently, subcutaneous off-label drug administration is often practised.AimTo assess the use,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have